Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,876
Closed -$692K 1242
2025
Q2
$692K Buy
6,876
+25
+0.4% +$1.91K ﹤0.01% 748
2025
Q1
$523K Buy
6,851
+93
+1% +$7.11K ﹤0.01% 829
2024
Q4
$467K Sell
6,758
-75
-1% -$5.4K ﹤0.01% 883
2024
Q3
$499K Buy
6,833
+163
+2% +$12K ﹤0.01% 884
2024
Q2
$447K Sell
6,670
-2,435
-27% -$94.4K ﹤0.01% 891
2024
Q1
$247K Sell
9,105
-385
-4% -$10.8K ﹤0.01% 1090
2023
Q4
$294K Sell
9,490
-119
-1% -$3.09K ﹤0.01% 1019
2023
Q3
$243K Sell
9,609
-156
-2% -$3.57K ﹤0.01% 1026
2023
Q2
$206K Buy
+9,765
New +$185K ﹤0.01% 1086
2023
Q1
Sell
-10,040
Closed -$201K 1169
2022
Q4
$201K Buy
+10,040
New +$194K ﹤0.01% 1071

Other funds holding INSM

Commerce Bank's INSM Position: Q3 2025 in Review

Commerce Bank sold out of Insmed (INSM) in Q3 2025, closing a stake of 6,876 shares — an estimated $692K sold.

Commerce Bank first reported a position in INSM in Q4 2022 and held it in 10 quarters. The position peaked at $692K in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Commerce Bank reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Commerce Bank sold 6,876 Insmed shares in Q3 2025, an estimated $692K.
  • Commerce Bank first reported a position in Insmed in Q4 2022 and held it in 10 quarters.
  • Commerce Bank's Insmed position peaked at $692K in Q2 2025.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Commerce Bank's 13F filing for Q3 2025, filed 12 Nov 2025.